Companies

Women students take top slots at Novartis BioCamp

Our Bureau Mumbai | Updated on March 13, 2018 Published on July 25, 2014

To represent India at global event to be held in Basle

Women have created history of sorts at the Novartis Biotechnology Leadership Camp (BioCamp) held in Hyderabad earlier this week.

Having taken the top three spots at the local BioCamp, it will be three women students who will represent India at the Novartis Biotechnology Leadership Camp in Basel, Switzerland, next month.

Satarupa Barma and Aditi Ramnath from the Indian School of Business (ISB), Hyderabad, and Nidhi Hans, who is pursuing a PhD at the International Centre for Genetic Engineering and Biotechnology (ICGEB), took top honours at the local event.

BioCamp has been held annually in Asian countries since 2004, starting in Taiwan as a local event. It has since grown to a global event. Around 60 students from around the world are expected to participate in the global BioCamp being held at the Novartis Campus in Basle, Switzerland from August 24 to 27.

Participation

Students go through a rigorous judging process before they are selected to participate in the country’s BioCamps. This time, 53 students from diverse faculties, including pharmacology, biotechnology, life sciences, finance, biomedical engineering, genetics, business management and immunology participated at the India event.

Institutes that participated included the Indian Institutes of Technology, Bombay and Kharagpur; the Indian Institute of Management Calcutta; the Fr Muller Medical College, Mangalore; NMIMS Bangalore; the Institute of Chemical Technology, Mumbai; BITS – Pilani; the Indian School of Business, Hyderabad and Mohali; Manipal University; Christian Medical College, Vellore; and JIPMER Puducherry, among others, Novartis said.

Speaking on the occasion, Ranjit Shahani, Novartis India’s Vice-Chairman and Managing Director, said the BioCamp maintains its position as a platform to provide students the opportunity to interact with leaders in the pharmaceutical area outside their area of study. “We hope to engage with a wider group of students as we grow the programme,” he added.

Others who participated in the function included Prof K Srinath Reddy, President, Public Health Foundation of India, who spoke on public health challenges in India and what needed to be learnt from other parts of the world; Vishy Chebrol, co-founder, India Life Science Funds, who focused on how entrepreneurs need to pitch for funding; and Dr Prabuddha Ganguli, Chief Executive Vision IPR, who focused on the value of intellectual property rights. Also participating in the event were Anu Acharya, Chief Executive, mapmygenome.com, who shared her entrepreneurial experience in preparing a business plan, and Juergen Brokatzky-Geiger, Novartis’ Global Head Corporate Responsibility.

>jyothi.datta@thehindu.co.in

Published on July 25, 2014

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
null
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.